BioPortfolio.com — the life science, pharmaceutical and healthcare portal
Breaking News at 20:54 EDT 10th March 2014
- 20:41 R-Tech Ueno: Announcement of Collaborative Research with Keio University for Treatment of Graft-versus-Host Disease (GVHD)
- 20:00 Frontotemporal Dementia Seminar with Expert Teepa Snow in Sarasota
- 20:00 China Summit paves the way for Australian companies
- 19:51 Santa Clara County Proclamation Marks 40th Anniversary of Satellite Healthcare
- 19:49 San Jose Commends Satellite Healthcare for 40 Years of Service to Kidney Disease Patients
- 19:43 Terason Launches New Company Website
- 19:32 BIO Applauds CMS for Withdrawing Problematic Part D Proposals
- 19:17 U.S. gay rights ruling won't be appealed, company says
- 19:15 TriVascular Technologies, Inc. Files Registration Statement for Proposed Initial Public Offering
- 19:02 ModusLink to Adjourn Annual Meeting with Respect to Proposal to Declassify Board of Directors
- 19:01 XFRA DIVIDEND INFORMATION - 12.03.2014 - 3
- 19:00 STC, a Health Informatics Company, Releases Its 2013 Public Health Annual Report
- 18:40 La Jolla Pharma's drug improves kidney function in trial, shares soar
- 18:35 Arthur Bruce Dental Partners with Patient Connect 365
- 18:20 New Site Focusing on Help and Treatment Options for Urinary Incontinence Launched
- 18:18 Salt Lake Chamber Features Suzette Musgrove
- 18:15 UPDATE 2-US administration pulls back on Medicare drug benefit proposals
- 18:10 Louisiana insurers to accept funds from federal AIDS program for Obamacare premiums
- 17:24 Comprehend Drives Discussion at Key Spring Conferences
- 17:23 Wright Medical Group, Inc. Announces Agreement with FDA Office of Device Evaluation to File PMA Amendment for Augment® Bone Graft In Lieu of Dispute Resolution Panel
- 17:08 La Jolla Pharma's drug improves kidney function in trial
- 17:00 GSK increases stake in Indian Pharmaceuticals subsidiary to 75 %
- 16:55 Buy Spiriva Online From Adv-Care Pharmacy
- 16:38 Opening Video
- 16:35 dpa-AFX Überblick: ANALYSTEN-EINSTUFUNGEN vom 10.03.2014: ASTRAZENECA, AXEL SPRINGER, BAYER, BAYWA, BEIERSDORF, BMW, BOEING, BRITISH AMERICAN TOBACCO, CONTINENTAL, DAIMLER, DEUTSCHE BANK, DEUTSCHE BOERSE, ...
Latest BioPortfolio blog: Most Alzheimer's drugs available treat symptoms not cause so new test is important breakthrough says Healthcare Analyst at The Economist Intelligence Unit
“This is the first time that researchers have developed a blood test that can predict who will go on to develop dementia or Alzheimer's, and it represents an important breakthrough. Research suggests that Alzheimer's begins developing years... — Read more
- Cell Lines From High-Risk Breast Tissue
- Pamidronate to Treat Osteogenesis Imperfecta in Children
- S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy
- Erlotinib Hydrochloride and Irinotecan Hydrochloride in Treating Patients With Advanced Solid Tumors
- Screening Evaluation for Women With Postpartum Depression
- Electronic Metal-Support Interactions in Single-Atom Catalysts.
- Production, purification and titration of a lentivirus-based vector for gene delivery purposes.
- Time-dependent enhancement of hippocampus-dependent memory after treatment with memantine: Implications for enhanced hippocampal adult neurogenesis.
- CT exposure in adult and paediatric patients: a review of the mechanisms of damage, relative dose and consequent possible risks.
- Genome-wide microarray analysis identifies a potential role for striatal retrograde endocannabinoid signaling in the pathogenesis of experimental L-DOPA-induced dyskinesia.